Spilling the RT

In this episode, Dr. John Christodouleas, Elekta’s Senior Vice President of Medical Affairs and Clinical Research, gives his take on scientific highlights from the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting, including promising evidence for MR-guided radiation therapy for prostate patients and the growing potential of low-dose radiation therapy for non-malignant conditions. He also addresses the ongoing debate around proton therapy and explains why he believes the future of radiation therapy is adaptive.

 

Tune in to hear why John thinks he has the best job in the world and who the newest member of the Medical Affairs team is.

In this episode, Dr. Alina Sturdza, radiation oncologist at the Medical University of Vienna dives into the latest breakthroughs in gynecologic cancer care, discussing the impact of MRI-guided adaptive brachytherapy and how the landmark international EMBRACE studies transformed cervical cancer treatment, leading to better survival rates, fewer side effects and improved quality of life.

 

Driven by a deep commitment to patient education, Dr. Sturdza emphasizes the HPV vaccination as a vital tool in preventing cervical and related cancers in both women and men. She also highlights the importance of patient advocacy in accessing specialized care and staying informed. Tune in to this episode of Spilling the RT for an in-depth look at the clinical benefits of brachytherapy, as she shares her optimism for its evolving role and her inspiring dedication to mentoring the next generation of brachytherapists.

In this episode, we delve into the potentially transformative world of low-dose radiotherapy for benign conditions with radiation oncologist and ASTRO Fellow Dr. Bobby Koneru, Chief of Radiation Oncology and Radiation Medicine at the Leonard C. Ferguson Cancer Center at FHN. Dr. Koneru discusses how, in addition to treating cancer, he uses low-dose radiation therapy to treat various functional diseases and inflammatory conditions to provide life-changing pain relief and improve the quality of life for patients with conditions like osteoarthritis. 

 

Tune in for a balanced discussion on the latest research, current challenges and the emerging role of LDRT in this insightful episode of Spilling the RT!

Radiation therapy plays a vital role in cancer treatment, with more than half of all people with the disease requiring it as part of their care. So why are only 36 percent of patients receiving it in the UK?

 

In this episode, Prof. Pat Price, Clinical Oncologist, founder and chair of Radiotherapy UK, chair and co-founder of the #catchupwithcancer campaign and co-founder of the Global Coalition for Radiotherapy, shares what drives her in the relentless advocacy for the role of radiotherapy in cancer care, and why raising its profile is essential to ensuring access for those who need it most. 

 

Ever wondered why there’s never been a medical television drama centered on radiation oncology? Tune in to hear what Prof. Price has to say about it!

In this episode, Dr. Arjun Sahgal, an international clinical and research leader in the field of high-precision stereotactic radiation to the brain and spine for both metastases and primary tumors, as well as oligometastases and the chief of radiation oncology at Sunnybrook Health Sciences Centre’s Odette Cancer Centre, shares his excitement around the initial results of the UNITED (Unity-Based MR-Linac Guided Adaptive Radiotherapy for High Grade Glioma) trial. UNITED is the world’s first adaptive MR-guided radiotherapy study for patients with high-grade gliomas, the most common and aggressive primary brain tumors found in adults, and the highlight of his illustrious career so far.

 

Dr. Sahgal has made challenging the dogma and changing the standard of care for patients whose cancer is considered “incurable” his trademark. But what inspires him? Tune in to episode 2 of Spilling the RT to find out.

Given the huge and increasing incidence of prostate cancer worldwide, enhancing the efficacy, safety and quality of prostate radiation therapy for men is crucial.

 

In this episode, Dr. Alison Tree, a clinical consultant oncologist who specializes in radiotherapy and chemotherapy for prostate cancer at the Royal Marsden Hospital NHS Foundation Trust, shares the different tools in her toolbox she uses to treat prostate patients. She also discusses why she chose the profession and the rationale around her belief that the future of prostate RT lies in fewer hospital visits, higher doses, and, with growing evidence, better patient experience.